Last 2,465
Change Today 0.00 / 0.00%
Volume 0.0
MZOR On Other Exchanges
Symbol
Exchange
OTC US
NASDAQ GM
Tel Aviv
Frankfurt
As of 10:24 AM 12/25/14 All times are local (Market data is delayed by at least 15 minutes).

mazor robotics ltd (MZOR) Snapshot

Open
$2,545
Previous Close
$2,571
Day High
$2,545
Day Low
$2,455
52 Week High
01/20/14 - $4,613
52 Week Low
11/25/14 - $1,860
Market Cap
1.0B
Average Volume 10 Days
239.6K
EPS TTM
$-0.33
Shares Outstanding
42.1M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for MAZOR ROBOTICS LTD (MZOR)

Related News

No related news articles were found.

mazor robotics ltd (MZOR) Related Businessweek News

No Related Businessweek News Found

mazor robotics ltd (MZOR) Details

Mazor Robotics Ltd., together with its subsidiary, Mazor Robotics Inc., is engaged in the development, production, marketing, and servicing of medical devices for supporting surgical procedures in the fields of orthopedics and neurosurgery in the United States, Western Europe, Eastern Europe, and Asia. The company operates in the field of image guided surgery and computer assisted surgery that enables the use of surgical instruments with precision and invasiveness. It offers Renaissance surgical guidance system that transforms spine surgery from freehand procedures to guided procedures. The company was formerly known as Mazor Surgical Technologies Ltd. and changed its name to Mazor Robotics Ltd. in 2010. Mazor Robotics Ltd. was founded in 2000 and is based in Caesarea, Israel.

113 Employees
Last Reported Date: 04/9/14
Founded in 2000

mazor robotics ltd (MZOR) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: $548.3K
Chief Executive Officer
Total Annual Compensation: $325.9K
Co-Founder and Chief Operating Officer
Total Annual Compensation: $299.1K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $388.9K
Vice President of Sales - United States
Total Annual Compensation: $464.5K
Compensation as of Fiscal Year 2013.

mazor robotics ltd (MZOR) Key Developments

Mazor Robotics Ltd. Receives Purchase Order for Two Renaissance Systems

Mazor Robotics Ltd. announced that it received a purchase order for two Renaissance systems from its distribution partner in China, Cicel (Beijing) Science & Technology CO. Ltd., reflecting the first systems sold into the Chinese market following the receipt of the China Food and Drug Administration (CFDA) approval to market the Renaissance system in China, in September 2014. The company also received a purchase order for one Renaissance system from its distribution partner in Taiwan, Pinnaclemed CO. Ltd. Subject to certain closing conditions, the system is expected to be installed at a newly opened spine hospital in Taiwan. This is the third system purchase by Pinnaclemed Co. Ltd. and will be the third Renaissance system in Taiwan.

Mazor Robotics Ltd. Presents at 26th Annual Piper Jaffray Healthcare Conference, Dec-02-2014 08:30 AM

Mazor Robotics Ltd. Presents at 26th Annual Piper Jaffray Healthcare Conference, Dec-02-2014 08:30 AM. Venue: The New York Palace Hotel, 455 Madison Ave, New York, NY 10022, United States. Speakers: Ori Hadomi, Chief Executive Officer and Director.

Mazor Robotics Ltd. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014

Mazor Robotics Ltd. reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, the company reported revenue of $6,091,000 compared to $3,109,000 a year ago. Loss from operations was $3,503,000 compared to $3,524,000 a year ago. Loss before taxes on income was $3,789,000 compared to $3,466,000 a year ago. Net loss attributable to ordinary shareholders was $3,873,000 or $0.09 basic and diluted per share compared to $3,529,000 or $0.10 basic and diluted per share a year ago. Non-GAAP operating loss was $2,806,000 compared to $3,132,000 a year ago. Non-GAAP net loss was $3,176,000 or $0.08 basic and diluted per share compared to $3,137,000 or $0.09 basic and diluted per share a year ago. Net cash used in operating activities was $3,994,000 compared to $1,999,000 a year ago. Purchase of property and equipment was $166,000 compared to $72,000 a year ago. For the nine months period, the company reported revenue of $15,463,000 compared to $14,259,000 a year ago. Loss from operations was $11,225,000 compared to $4,861,000 a year ago. Loss before taxes on income was $11,450,000 compared to $18,336,000 a year ago. Net loss attributable to ordinary shareholders was $11,607,000 or $0.28 basic and diluted per share compared to $18,499,000 or $0.61 basic and diluted per share a year ago. Non-GAAP operating loss was $9,707,000 compared to $3,961,000 a year ago. Non-GAAP net loss was $10,089,000 or $0.24 basic and diluted per share compared to $4,089,000 or $0.13 basic and diluted per share a year ago. Net cash used in operating activities was $12,420,000 compared to $3,791,000 a year ago. Purchase of property and equipment was $407,000 compared to $223,000 a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MZOR:IT 2,465.00 0.00

MZOR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Elekta AB kr80.95 SEK -0.35
Medtronic Inc $73.61 USD -0.47
MRI Interventions Inc $0.87 USD -0.04
Siemens AG €94.23 EUR +0.392
Stryker Corp $95.64 USD -0.36
View Industry Companies
 

Industry Analysis

MZOR

Industry Average

Valuation MZOR Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MAZOR ROBOTICS LTD, please visit www.mazorrobotics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.